Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Regina, Deja"'
Autor:
Mariusz Lupa, Agnieszka Pardała, Anna Bednarek, Jolanta Mrochem-Kwarciak, Regina Deja, Katarzyna Mizia-Stec, Aureliusz Kolonko
Publikováno v:
Diagnostics, Vol 14, Iss 12, p 1310 (2024)
Overhydration and cardiac function abnormalities are common in hemodialysis patients. The association of N-terminal prohormone for brain natriuretic peptide (NT-proBNP) and other fluid status biomarkers with echocardiographic parameters of heart fail
Externí odkaz:
https://doaj.org/article/880c441197b146cbb7186cdd8d9e7d4f
Autor:
Seweryn Gałecki, Agnieszka Gdowicz-Kłosok, Regina Deja, Barbara Masłyk, Monika Giglok, Rafał Suwiński, Dorota Butkiewicz
Publikováno v:
Cells, Vol 12, Iss 23, p 2721 (2023)
Osteopontin (OPN)-CD44 signaling plays an important role in promoting tumor progression and metastasis. In cancer, OPN and CD44 overexpression is a marker of aggressive disease and poor prognosis, and correlates with therapy resistance. In this study
Externí odkaz:
https://doaj.org/article/b88961d69604437cb4549192dba89df9
Autor:
Rafał Suwinski, Monika Giglok, Katarzyna Galwas-Kliber, Adam Idasiak, Bozena Jochymek, Regina Deja, Barbara Maslyk, Jolanta Mrochem-Kwarciak, Dorota Butkiewicz
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Several studies have documented that blood biomarkers can improve basic prognostic models in radiotherapy and radio-chemotherapy for non-small cell lung cancer. The current study evaluated the prognostic impact of six markers focu
Externí odkaz:
https://doaj.org/article/3a701466b582403a8640fc1565907611
Autor:
Agata Hajduk, Regina Deja, Andrzej Wygoda, Jolanta Mrochem-Kwarciak, Krzysztof Składowski, Tomasz Rutkowski
Publikováno v:
Tumori Journal. 104:273-279
Purpose: There is a lack of effective diagnostic tools for early assessment of radiotherapy (RT) outcome in patients with head and neck cancer (HNC). The timely diagnosis of treatment failure may facilitate use of salvage procedures to prevent diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::977a3d972e374530e7c448e6d788c1dc
https://doi.org/10.5301/tj.5000639
https://doi.org/10.5301/tj.5000639
Autor:
Tomasz Rutkowski, Krzysztof Składowski, Aleksandra Chmura, Jolanta Mrochem-Kwarciak, Regina Deja, Andrzej Wygoda
Publikováno v:
Oral Oncology. 118:5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84d1e2efe1d0600961a58a51d4bb74bd
https://doi.org/10.1016/s1368-8375(21)00334-1
https://doi.org/10.1016/s1368-8375(21)00334-1
Autor:
Regina Deja, Agnieszka M. Mazurek, Andrzej Wygoda, Jolanta Mrochem-Kwarciak, Tomasz Rutkowski, Krzysztof Składowski, Aleksandra Chmura
Publikováno v:
Oral Oncology. 118:5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0013f698f4a709401fe6516c32c53f37
https://doi.org/10.1016/s1368-8375(21)00301-8
https://doi.org/10.1016/s1368-8375(21)00301-8
Autor:
Andrzej Wygoda, Tomasz Rutkowski, Regina Deja, Krzysztof Składowski, Aleksandra Chmura, Jolanta Mrochem-Kwarciak
Publikováno v:
Oral Oncology. 118:4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e764307d75a8c76b00f1f2d443ed76
https://doi.org/10.1016/s1368-8375(21)00333-x
https://doi.org/10.1016/s1368-8375(21)00333-x
Autor:
Dorota Butkiewicz, Monika Giglok, Barbara Masłyk, Jolanta Mrochem-Kwarciak, Bozena Jochymek, Katarzyna Galwas-Kliber, Rafał Suwiński, Adam Idasiak, Regina Deja
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Background Several studies have documented that blood biomarkers can improve basic prognostic models in radiotherapy and radio-chemotherapy for non-small cell lung cancer. The current study evaluated the prognostic impact of six markers focusing on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e59dbdf471a9ad267d69b0d02f76b671
https://pubmed.ncbi.nlm.nih.gov/31068179
https://pubmed.ncbi.nlm.nih.gov/31068179
Autor:
Jolanta, Mrochem-Kwarciak, Izolda, Mrochen-Domin, Andrzej, Wojcieszek, Regina, Deja, Aleksandra, Chmura, Barbara, Masłyk, Elzbieta, Nowara, Beata, Kaleta, Zofia, Kołosza, Wiesława, Bartnik
Publikováno v:
Ginekologia polska. 82(12)
Currently CA 125 is a marker of choice for monitoring ovarian cancer Nonetheless, scientists are still searching for new markers, which could provide additional information for the evaluation of treatment, especially in patients with normal CA 125 le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58d71a677cb96464a99b76ae846849e5
https://pubmed.ncbi.nlm.nih.gov/22384627
https://pubmed.ncbi.nlm.nih.gov/22384627
Autor:
Piotr Widlak, Lukasz Marczak, Rafal Tarnawski, Maciej Stobiecki, Aleksandra Chmura, Andrzej Polański, Elżbieta Nowicka, Anna Walaszczyk, Katarzyna Behrendt, Joanna Polanska, Monika Pietrowska, Regina Deja
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 7, Iss 1, p 60 (2009)
Journal of Translational Medicine, Vol 7, Iss 1, p 60 (2009)
Background Mass spectrometric analysis of the blood proteome is an emerging method of clinical proteomics. The approach exploiting multi-protein/peptide sets (fingerprints) detected by mass spectrometry that reflect overall features of a specimen's p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d558c82c622882a597b53f9be807b5
https://doi.org/10.1186/1479-5876-7-60
https://doi.org/10.1186/1479-5876-7-60